Aims: There is little information about transmembrane protein 35B (TMEM35B) expression in glioma, and its functions in glioma remains no clue.
Patients & Methods: Immunohistochemistry was used to measure TMEM35B expression levels and CCK8 and Transwell assays were analyzed the proliferative and migratory and invasive.
Results: TMEM35B protein was significantly higher in gliomas and correlated with a higher tumor TNM stages.